Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system

Annals of Pharmacotherapy

Volumn 42, Issue 10, 2008, Pages 1491-1496

  Ortega, Ana ^a   Aguinagalde, Aránzazu ^a,b   Lacasa, Carlos ^a   Aquerreta, Irene ^a   Fernández Benítez, Margarita ^a   Fernández, Luis M ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Pharmacy Service   (Spain)

Author keywords

Adverse drug reaction reporting systems; Hospital information systems; Medical informatics

Indexed keywords

CYTOTOXIC AGENT; DRUG; MONOCLONAL ANTIBODY; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ARTICLE; AUTOMATION; COMPUTER SYSTEM; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; GASTROINTESTINAL DISEASE; HOSPITAL INFORMATION SYSTEM; HUMAN; MEDICAL DOCUMENTATION; MEDICAL INFORMATICS; NURSE; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; UNSPECIFIED SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HOSPITAL BED CAPACITY, 300 TO 499; HOSPITAL INFORMATION SYSTEMS; HOSPITALS, PRIVATE; HUMANS; NURSES; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES;

EID: 52949096153     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L130     Document Type: Article

References (11)

1. Montasturc JL, Sommet A, Lacroix I, et al. Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. Joint Bone Spine 2006;73:629-32.
2. Figueiras A, Herdeiro MT, Polónia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006;296:1086-93.
3. Lee SB, Schepers GP, Goldberg KL. Electronic adverse-drug-reaction- reporting program. Am J Health-Syst Pharm 2004;61:1230-2.
4. Ley 29/2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios. Boletín Oficial del Estado 2006;178:28122-65.
5. Centro de farmacovigilancia de Navarra. Boletín Informativo Farmacovigilancia 2005;26:2-4.
6. Ulfvarson J, Mejyr S, Bergman U. Nurses are increasingly involved in pharmacovigilance in Sweden. Pharmacoepidemiol Drug Saf 2007;16:532-7.
7. Morrison-Griffiths S, Walley TJ, Park BK, Breckenridge AM, Pirmohamed M. Reporting of adverse drug reactions by nurses. Lancet 2003;361:1347-8.
8. Van Grootheest K, Olsson S, Couper M, Jong-van den Berg L. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004;13:457-64.
9. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001;51:81-6.
10. Van Grootheest AC, Jong-van den Berg LT. The role of hospital and community pharmacists in pharmacovigilance. Res Social Adm Pharm 2005;1:126-33.
11. Vallano A, Cereza G, Pedròs C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol 2005;60:653-8.